Jude Onyia
Chief Tech/Sci/R&D Officer bei NEUROCRINE BIOSCIENCES, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jude Onyia is currently the Director at Voyager Therapeutics, Inc. and the Chief Scientific Officer at Neurocrine Biosciences, Inc. Prior to his current roles, he worked at Eli Lilly & Co. for 26 years, where he held the position of Vice President-Biotechnology Discovery Research from 2014 to 2021.
He also briefly served as the Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Onyia received his undergraduate degree from The State University of New York and his doctorate from the State University of New York at Downstate Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.02.2024 | 13 128 ( 0,01% ) | 2 Mio $ | 31.03.2024 | |
| 06.06.2023 | 2 910 ( 0,01% ) | 27 092 $ | 31.03.2024 |
Aktive Positionen von Jude Onyia
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30.11.2021 |
| VOYAGER THERAPEUTICS, INC. | Director/Board Member | 21.02.2023 |
Ehemalige bekannte Positionen von Jude Onyia
| Unternehmen | Position | Ende |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.06.2021 |
Ausbildung von Jude Onyia
| The State University of New York | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
